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of Washington Hospitals
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and Dean G. Smith, PhD3
Abstract
This longitudinal study examines whether readmission rates, made transparent through Hospital Compare, affect hospital financial 
performance by examining 98 hospitals in the State of Washington from 2012 to 2014. Readmission rates for acute myocardial 
infarction (AMI), pneumonia (PN), and heart failure (HF) were examined against operating revenues per patient, operating 
expenses per patient, and operating margin. Using hospital-level fixed effects regression on 276 hospital year observations, the 
analysis indicated that a reduction in AMI readmission rates is related with increased operating revenues as expenses associated 
with costly treatments related with unnecessary readmissions are avoided. Additionally, reducing readmission rates is related 
with an increase in operating expenses. As a net effect, increased PN readmission rates may show marginal increase in operating 
margin because of the higher operating revenues due to readmissions. However, as readmissions continue to happen, a gradual 
increase in expenses due to greater use of resources may lead to decreased profitability.
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Original Research
What do we already know about this topic?
Answer—Under the Affordable Care Act, readmission rates have become transparent and hospitals are under financial 
stress for having excess readmission rates.
How does your research contribute to the field?
Answer—In the stream of research articles that examine the quality and finance relationship within the healthcare field, 
this is one of the first studies that examines readmission rates and financial performance measures as defined by operat-
ing revenues per patient, operating expenses per patient, and operating margin as outcomes.
What are your research’s implications toward theory, practice, or policy?
Answer—Our findings would guide managers in strategizing ways to change health management practices to seek a 
balance between reducing readmission rates and maintaining profitability.
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Introduction
Transparency pertaining to quality of care data as captured 
through measurement and reporting is a growing issue for hos-
pitals and health services organizations.1-3 The avalanche cre-
ated by the 1999 Institute of Medicine (IOM) report “To Err Is 
Human” and the Patient Safety and Quality Improvement Act 
of 2005, which became a law under the Bush administration, 
together laid the foundation for mandatory reporting require-
ments by Centers for Medicare and Medicaid Services 
(CMS).4,5 Then, in 2009, under the Obama administration and 
as part of the Patient Protection and Affordable Care Act 
(ACA), CMS began reporting 30-day readmission rates for 
acute myocardial infarction (AMI), pneumonia (PN), and heart 
failure (HF) on its website.6,7 The Hospital Readmission 
Reduction Program (HRRP) was designed as a Medicare 
value-based purchasing program that decreases payments to 
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hospitals that have disproportionately high readmissions.6 
Beginning in 2012, the HRRP assessed penalties based on a 
hospitals’ performance on six conditions or procedures includ-
ing AMI, chronic obstructive pulmonary disease (COPD), 
heart failure (HF), PN, coronary artery bypass graft surgery, 
and elective primary total hip arthroplasty and/ortotal knee 
arthroplasty.6 In the duration of the program, the penalties have 
increased from 1% to 3% (or a factor of .97) for hospitals with 
excessive readmissions.6 Policymakers envisioned that pub-
licly reporting quality measures including readmission rates 
would increase transparency of the quality of care delivered by 
hospitals. Transparency of quality indicators would encourage 
the patient to choose a hospital that offers comparatively better 
care as well as provide benchmarks for hospitals as they engage 
in quality improvement efforts to reduce readmission rates.
In addition, hospitals have at least two incentives to reduce 
readmission rates.8 Specifically, transparency through public 
reporting provides an incentive to reduce readmission rates, to 
avoid “shaming.”1 Hospitals that have high readmission rates 
might deter future patients from choosing them. Reputation 
for quality has been discussed as a driver for profits through its 
effect on increased market share and hospitals may have the 
incentive to decrease their readmission rates to avoid develop-
ing a bad reputation.9 Furthermore, hospitals get penalized 
under the CMS Readmission Reduction Program for having 
excess readmission rates.6 For instance, as noted by Byrnes,2 
readmission penalties in 2017 exceeded a half billion dollars. 
Avoiding these sizable financial penalties is a second incentive 
for hospitals to reduce their readmission rates.
Nevertheless, transparency stimulates accountability, 
while informing patients about the wide variation in quality 
of healthcare across hospitals.10 While being held account-
able may create pressure among hospital administrators to 
reduce readmission rates, reducing readmissions by dis-
charging patients too early may not really be a cost saving or 
profitable strategy if those patients must return to the hospi-
tal.11 On the other hand, however, high readmissions rates 
may be generating an inpatient revenue stream, a problem 
that policymakers are trying to address.
Therefore, the purpose of this study is to further contribute 
to the literature by examining the association between pub-
lished readmission rates and hospital financial performance. It 
is important for practitioners and policy makers to understand 
the financial implications of readmission reduction as they go 
through the stressful process of being increasingly transparent. 
Understanding the financial implications of readmission rate 
transparency can assist hospital leaders to employ a variety of 
strategies like expedited discharge or designing innovative 
quality improvement initiatives,7 which would influence rev-
enues, expenses, and profit margins in divergent ways.
New Contributions
This article makes a new contribution in the stream of research 
articles that examine the quality and finance relationship 
within the healthcare field. This is one of the first studies that 
examines readmission rates and financial performance mea-
sures as defined by operating revenues per patient, operating 
expenses per patient, and operating margin as outcomes. We 
located one study, for instance, that examined the relationship 
between average profitability of patient admissions and read-
mission rates, which found no evidence of an association 
between them.12 To the best of our knowledge, there is still a 
gap in the literature on research that evaluates the longitudinal 
impact of transparently reported quality of care metrics on 
average hospital financial performance. Finally, this study 
contributes through the use of a fixed-effects regression meth-
odology. By using a fixed-effects methodology, we control for 
any unobserved factors that don’t change over time such as 
policy effects regarding readmission reduction.
In addition, whereas much has been written about how 
transparency in quality measures influences consumer’s 
choice behaviors10 or influences payment for services,3 our 
paper, instead, seeks to evaluate the association between 
transparently reported readmission rates and hospital finan-
cial performance. Findings from this study offer guidance 
to healthcare managers on ways to position their organiza-
tions adequately to achieve reduction in readmission rates 
while maintaining decent profitability. Through this 
research, policymakers gain an insight on the effects of 
having transparent readmission rates including financial 
penalties and lower reimbursements on hospital financial 
performance.
Transparency in Quality Reporting: An 
Overview
Several legislative efforts and endeavors from independent 
organizations sparked the evolution that created the current 
transparency of quality metrics that includes both process 
and outcome indicators.
Department of Health and Human Services
One of the first legislative movements toward quality trans-
parency included the Congressional hearings that were held 
in 1999 as a reaction to the IOM “To Err Is Human” report.13 
The IOM report instilled the importance of reducing adverse 
medical events and complications by estimating the number 
of deaths each year due to medical errors.13 Consequently, 
the Department of Human and Health Services (DHHS) 
formed a subcommittee with the key purpose of evaluating 
the pros and cons of data transparency through voluntary and 
mandatory reporting systems.14 The subcommittee recom-
mended more aggressive drug surveillance, increased avail-
ability of federal demonstration waiver projects in an effort 
to assert comparative effectiveness, and the proposal of bills 
that covered the differences in mandatory (eg, for serious 
errors) and voluntary reporting systems (eg, for minor errors 
and “close calls”).14
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National Aeronautics and Space Administration
Around the same time of the DHHS debates, the National 
Aeronautics and Space Administration (NASA) created the 
confidential and voluntary Patient Safety Reporting System.15 
Modeled after a previously created aviation safety reporting 
system, the PSRS is meant as a complement to a medical 
entity’s existing reporting systems and designed to report 
safety-related concerns such as unexpected injuries or occur-
rences, safety ideas, “close calls,” or even lessons learned.15
Joint Commission
In 1998, the Joint Commission on Accreditation of Healthcare 
Organizations (JCAHO), launched one of the first national 
programs on measurement of hospital quality that required 
reporting of performance measures to increase transpar-
ency.16 As a result, in 2002, all accredited hospitals were 
required to collect and report data on performance for core 
measures, which were made available to public in 2004.3 As 
of 2010, hospitals reported data on 57 quality measures; a list 
that JCAHO intends to expand with the inclusion of other 
measures such as deaths and readmissions.3,17
Centers for Medicare and Medicaid Services
In 2004, CMS began imposing financial penalties on hos-
pitals that did not report to CMS the same performance 
data that they made transparent to JCAHO. Then in 2005, 
CMS began its own public reporting of quality measures to 
make these data available and transparent to public.18 
Consistent with this trend, the ACA19 provided the greatest 
impetus for collection and reporting of quality of care data. 
Through this act, public reporting for hospitals and physi-
cians has increased and improved over the past few years.19 
And currently, CMS uses its Hospital Compare website20 
to provide transparency on both process and outcome qual-
ity indicators.
Readmission Rates as a Measure of Quality and 
Hospital Financial Performance
Hospital readmission is defined as “a hospital admission that 
occurs within a specified time frame after discharge from the 
first admission.”21 Readmission rates have been considered a 
hospital quality measure22,23 and have been shown to reflect 
dimensions of quality of patient care.24,25 Prior studies have 
discussed the relationship between readmissions, length of 
stay, cost of care, and mortality.26 For instance, in-hospital 
mortality has been found to be higher for patients who are 
readmitted versus those who are not.26,27 Other researchers 
argue that readmissions lead to an increased length of stay 
and expenditure of more hospital resources.28,29 But a recent 
study argues that low cost hospitals that spend fewer 
resources had readmission rates that were only slightly 
higher or similar to the hospitals that are high cost or spend 
more resources.11 Consequently, the present study adds to 
this literature by examining readmissions as associated with 
hospital financial performance.
One way to measure hospital financial performance is 
through hospital profitability. Studies on profitability com-
monly use margins, which reveal the percentage of revenue 
that is left after expenses have been paid.30-32 Other studies, 
however, measured profitability by examining net income 
from direct care services33 patient revenues, or the ratio of 
cash flow to total revenues.34 Given that readmissions are a 
part of direct patient care expenses and revenues, our study, 
instead, examines the financial indicators of operating reve-
nues per patient, operating expenses per patient, and operat-
ing margin as outcomes.
While some researchers have examined the impact of 
profitability on quality,35,36 others have assessed the relation-
ship of quality on profitability. For example, a study that 
tested the impact of profitability on quality indicated that 
operating cash flow is inversely related to mortality rates of 
heart attack, HF, and PN.37 However, hospital profitability 
has been well-documented in the literature as an outcome of 
various determinants including but not limited to patient 
mix, managerial policies, and quality outcomes.38-40 As such, 
studies that have assessed the impact of quality on profitabil-
ity have argued that poor-quality hospitals may lead to poor 
profits and have demonstrated that low-quality hospitals 
experienced below average profits.35 Other scholars have 
found that generally better quality led to better profits.41 
However, increase in treatments such as higher readmission 
rates and higher use of technology contributes to increase in 
profits, even though it means that the care may not be effec-
tive.39 This study sheds further light on hospital quality and 
financial performance relationship by specifically focusing 
on readmission rates as the quality indicator.
Theoretical Perspective and 
Hypotheses
Resource Dependence Theory (RDT) posits that an organiza-
tion’s survival relies on its ability to acquire resources from 
the external environment.42 This interdependence between 
the organization and environment can create a power imbal-
ance due to asymmetric resource distribution.42
Relevant to the present study, RDT has been presented 
using “munificence” as one of its various perspectives.43 
Munificence relates to the abundance and availability of 
resources in an organization’s external environment.43 When 
resources become scarce and less abundant, organizations 
adopt strategies to survive. Hospitals rely on reimbursement 
from outside agencies such as CMS and private insurers for 
payments regarding readmissions. In the current payment 
scenario, it has become increasingly difficult for hospitals to 
obtain funding from external resources. In addition, hospitals 
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have to pay financial penalties for having excess readmission 
rates. While the environment has become less munificent, 
hospitals have adopted readmission reduction strategies to 
reduce potential readmissions and financial penalties associ-
ated with them. This suggests that hospitals may not get fully 
reimbursed for having readmissions and would also have to 
pay additional penalties. Stated differently, a decline in 
unnecessary penalties pertaining to avoidable readmissions, 
instead being reimbursed at higher rates, are likely to increase 
operating revenues per patient. In addition, lower readmis-
sions would improve hospital quality indicators that drives 
patients and an in-stream of revenues. Thus, we hypothesize 
that
Hypothesis 1 (H1): Reduction in readmission rates is 
associated with an increase in operating revenues per 
patient.
To reduce environmental interdependence and uncer-
tainty, organizations adopt various strategies to obtain and 
stances to preserve resources.42 One of these postures, may 
be, to focus on internal operations.44 Changes in internal 
operations that are oriented toward quality improvement 
may include improving readmission rates by investing in 
readmission reduction strategies such as implementing 
robust home healthcare programs, ensuring smooth transi-
tional care and joining a readmission prevention-focused 
collaborative.45,46 In other cases, reducing length of patient’s 
stay in hospitals may reduce readmission rate.47 However, 
the choice of internal strategy used in reducing readmission 
would influence financial outcomes, for instance, investment 
in activities to reduce readmissions may increase operating 
expenses per patient. For example, the amount spent in assur-
ing good discharges or communicating patients about their 
follow-up plan is likely be an additional financial burden to 
the hospital. Stated differently, additional expenses may be 
incurred through engaging in a variety of readmission reduc-
tion and proper discharge programs. Therefore, we hypothe-
size the following:
Hypothesis 2 (H2): Reduction in readmission rates is 
associated with increased operating expenses per patient.
To reduce the effects of lack of abundant resources and 
environmental uncertainty, hospitals may engage in readmis-
sion reduction strategies that may be expensive but effective. 
While hospitals may achieve a reduction in expenses by 
avoiding future readmissions, they may also observe an 
increase in their expenses due to investment in readmission 
reduction strategies. Based on the above two hypotheses, we 
also examine if as a net effect, readmissions are associated 
with changes in operating margins. Operating margin is an 
indicator of hospital’s profitability and involves revenues 
and expenses related with direct patient care only. It is a 
function of both operating revenues and expenses. Higher 
expenses due to additional expenditures associated with 
investment in readmission reduction programs, may reduce 
the operating margins because expenses would exceed reve-
nues. As such, we hypothesize the following:
Hypothesis 3 (H3): Reduction in readmission rates is 
associated with operating margin.
To summarize, readmissions are costly expenses for hos-
pitals. Instead of spending resources on complicated proce-
dures and patients with high severity, hospitals could 
streamline their resources into having more initial admis-
sions for patients who have less severity, or invest resources 
into proper discharge and readmission reduction programs. 
With a focus on detailed discharge planning and efforts 
toward reducing readmissions, the average length of stay 
may slightly increase, which might be associated with higher 
operating expenses. However, ensuring that those patients do 
not return with complications, would permit the allocation of 
more time and resources to be used toward those patients 
with initial admissions. This would be associated with an 
increase in operating revenues. Finally, we expect to see that 
a reduction in readmission rates would be associated with 
operating margin. It is possible that expenses incurred as a 
result of proper readmission reduction programming and dis-
charge planning, may be related with a decrease in the over-
all operating margin.
Methods
Data and Sample
Data for readmission rates were obtained from Centers of 
Medicare and Medicaid Services’ Hospital Compare. 
Financial data on inpatient visits was obtained from informa-
tion provided by Department of Health, State of Washington 
and the Medicare Cost Reports.48 Information on total num-
ber of outpatient visits was obtained from the American 
Hospital Association’s (AHA) annual survey each for 2012, 
2013, and 2014. All datasets were merged using Medicare 
provider numbers as the primary identifier. The total number 
of hospitals in the dataset was 98, which included all the hos-
pitals in Washington between the time period 2012-2014, 
and data were organized in a panel format at the hospital 
level. Since data were missing at random, missing values 
were neither removed nor filled in, which left a total of 276 
hospital year observations. All analysis was performed in 
Stata version 15.49
Measures
Independent variables. We examine the relationship between 
30-day unadjusted AMI, PN, and HF readmission rates with 
operating revenues per patient, operating expenses per 
patient and overall operating margin. Thirty-day unadjusted 
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readmission rates for AMI, PN, and HF are defined as admis-
sion to a hospital within 30 days of a discharge from the 
same or another diagnosis.6
Dependent variables. Operating revenue per patient is the 
total operating revenue divided by total adjusted discharges. 
Operating expenses per patient is the total operating expenses 
divided by total adjusted discharges. Total adjusted dis-
charges take into account both outpatient visits and dis-
charges. It was computed by adding the total discharges to 
the product of outpatient equivalent discharges and total out-
patient visits. Outpatient equivalent discharges were com-
puted by dividing inpatient revenue per discharge by 
outpatient revenue per outpatient visit.
Operating margin is calculated as the difference between 
hospital operating revenues and operating expenses, also 
known as operating income, divided by operating revenues.50 
CMS publishes rolling readmission rates on Hospital 
Compare. This means that the year 2012 includes readmis-
sion rates from 2008 to 2011, 2013 includes readmission 
rates from 2009 to 2012, and 2014 includes readmission 
rates from 2010 to 2013. We have considered average hospi-
tal operating margin for state of Washington hospitals for 
each of these years.
Control variables. Control variables used in this analysis 
include 30-day unadjusted mortality rates for AMI, PN, and 
HF. Thirty-day unadjusted mortality rates for AMI, PN, and 
HF estimate the death within 30 days of a hospital admission 
for patients hospitalized with AMI, PN, and HF, respec-
tively.6 Mortality rates have been used as a control variable 
because patients who die within 30 days will not be readmit-
ted, which suggests that hospitals that have poor quality and 
high number of mortalities during this period may have low 
readmission rates.12 Additionally, by including mortality 
rates as control variables, we expect to increase the explana-
tory power of our models.
Data Analysis
This study employs a fixed-effects regression model, a meth-
odology not previously used in this line of research. The 
rationale behind using hospital level fixed effects is that it 
will control for any baseline time constant unobserved fac-
tors that may lead a hospital to select particular readmission 
reduction strategies, which may affect readmission rates, our 
explanatory variable. Policies regarding how to reduce read-
mission rates may vary across hospitals and a fixed effects 
methodology can help control for that variation. This method 
would also minimize selection bias issues (hospital charac-
teristics that would lead a hospital into selecting certain read-
mission strategies) to properly show the association between 
reducing readmission rates and profitability of hospitals.51 A 
distribution of hospitals by characteristics was also deter-
mined. Following is the empirical model for the fixed-effects 
regression for the explanatory variable, readmission rates
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Subscripts i and t represent the ith hospital in the tth year 
and v
i
 is the hospital fixed effect. Robust standard errors are 
reported to account for variability of our dependent variable, 
profit margins, across values of independent variable, the 
readmission rates (also known as heteroskedasticity).
Results
Descriptive Statistics
Table 1 presents the results of distribution of hospital charac-
teristics. The average hospital size, represented by the num-
ber of beds is 225, with a SD of 148. Most of the hospitals in 
the sample were not-for-profit (68.9%), followed by govern-
ment (23%), and for-profit (8%). Majority of the hospitals in 
this sample were located in metro areas (84%), followed by 
non-metro areas (16%). More than half of the hospitals were 
non-teaching (52%), and the remaining were teaching (48%).
Table 1. Distribution of Hospitals by Characteristics (n = 276).
Hospital characteristics
 Mean SD
 Frequency %
Hospital size 225 beds 147.92 beds
Ownership
 Not-for profit 190 68.84
 For-profit 23 8.33
 Government 63 22.82
Location
 Metro 233 84.4
 Non-metro 43 15.5
Teaching
 No 143 51.81
 Yes 133 48.18
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Descriptive statistics on the sample of hospitals (N = 
276) are given in Table 2. The average operating revenues 
per patient is higher in 2014 than in 2013 by $9602 and in 
2012 by $10,511. Similarly, the mean operating expenses per 
patient is higher in 2014 than in 2013 by $9508 and in 2012 
by $9436. The average operating margin in 2014 is higher by 
2.56 percent points in 2013 and by 3.95 percentage points in 
2012. The average readmission rates for both AMI and PN 
showed an increase in 2014 by approximately 3-4 percentage 
points, but for HF, the readmission rate increased by 
approximately 1 percent point in 2014 as compared to the 
prior 2 years. However, average overall HF readmission 
rates were higher than the average overall AMI and average 
overall PN readmission rates by approximately 5 percent 
points. The average mortality rate for AMI, HF, and PN 
shows consistency (approximately 12%-16%) across the 
years and across diagnoses. The descriptive statistics reveal 
a trend, whereby, operating expenses per patient becomes 
higher when readmission rates increase. In addition, we see a 
trend of increasing operating revenues per patient and 
increasing overall operating margin in those years that show 
higher readmission rates across all diagnoses.
Regression Analyses
Results from the fixed-effects regression models are pro-
vided in Table 3. It should be noted that in examining fixed 
effects model as compared to an ordinary least squares 
regression model (not shown), the adjusted R2 was higher for 
fixed effects model with 75%-78% explained variance. Eta 
squared (effect size) and F statistics for each model have also 
been reported in Table 3.
Our first hypothesis posited that a reduction in readmis-
sion rates would associate with an increase in operating rev-
enues per patient. Based on the model for AMI 30-day 
readmission rates, we can infer that a 1 percent point decrease 
in AMI readmission rate is associated with a $50 increase in 
operating revenues per patient. PN readmission rate and HF 
30-day readmission rate had no association with operating 
revenues per patient. Thus, our first hypothesis was partially 
supported.
Our second hypothesis suggested that a reduction in read-
mission rates would associate with increased operating 
expenses per patient. Our first model for AMI readmission 
rates shows that, a 1 percent point decrease in AMI readmis-
sion rate is related with a $51 increase in operating expenses 
per patient. PN readmission rates and HF readmission rates 
were not related with operating expenses per patient. 
Therefore, our second hypothesis was partially supported.
Finally, our hypothesis about net effect posited that a 
reduction in readmission rates would be associated with 
operating margins was partially satisfied. Of the three mod-
els, higher PN readmission rates showed a positive relation-
ship with overall operating margin. Specifically, on an 
average, a 10 percent point increase in PN readmission rate 
is associated with approximately one percent point increase 
in operating margin. Therefore, our third hypothesis was par-
tially supported.
Discussion and Conclusion
A key finding of this study is that readmission rates have a 
variable association with different indicators of financial 
performance. Given that readmission rates have become 
Table 2. Descriptive Statistics, State of Washington Hospitals  
(n = 276).
Descriptive statistics Mean SD
Dependent variables
 Operating revenues/pt (in $)
  2012 20357.37 4334.2
  2013 21266.82 6130.9
  2014 30869.01 15101.05
 Operating expenses/pt (in $)
  2012 20437.38 4388.78
  2013 20365.61 5551.14
  2014 29873.54 14579.17
 Operating margin (in %)
  2012 -0.89 2.14
  2013 0.5 2.25
  2014 3.06 0.96
Independent variables
  AMI 30-day readmission rate  
  2012 15.98 0.98
  2013 15.68 0.84
  2014 19.48 2.85
 Pneumonia 30-day readmission rate
  2012 15.89 0.43
  2013 15.08 0.52
  2014 18.58 1.97
 Heart failure 30-day readmission rate
  2012 22.21 0.58
  2013 20.78 0.54
  2014 22.32 2.86
Control variables
 AMI 30-day mortality rate
  2012 16.15 0.26
  2013 15.84 0.21
  2014 15.53 0.2
 Pneumonia 30-day mortality rate
  2012 12.3 0.18
  2013 12.37 0.18
  2014 12.58 0.2
 Heart Failure 30-day mortality rate
  2012 12.63 0.2
  2013 12.71 0.18
  2014 12.92 0.15
Note. AMI = acute myocardial infarction.
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transparent and hospitals are being financially penalized for 
having high readmission rates, organizations have become 
more aggressive in managing clinical practices related with 
conditions that usually end up in readmissions, for instance, 
AMI. Overall, our results show that operating revenue per 
patient was significantly associated with AMI (H1) that 
operating expenses per patient was significantly associated 
with AMI (H2), and operating margins associated with PN 
(H3).
More specifically, in the case of AMI, results showed that 
a reduction in readmission rate is related with higher operat-
ing revenues as well as higher operating expenses. This find-
ing is consistent with other studies that found varying 
relationships between AMI and financial performance.52 
AMI is a costly condition that is expensive for a hospital to 
treat initially as well as during readmissions. Improvement in 
the quality of discharge planning for these patients as a strat-
egy of avoiding readmissions can increase up-front operating 
expenses in the hopes of avoiding regulatory penalties and 
the costs of readmission stays later. For example, a high-
quality discharge planning may include individualized dis-
charge plans in addition to post discharge support, medication 
management, and follow ups with pharmacist that may add 
to operating expenses.53
Furthermore, in the case of AMI, reducing the readmis-
sion rates may yield cost savings for the hospital due to treat-
ments not rendered because unnecessary readmission were 
avoided, which may be reflected in the form of higher oper-
ating revenues. Due to the complexity of the condition and 
the reimbursement structure, AMI also has the potential to 
yield higher operating revenue in the payment for related ser-
vices such as percutaneous coronary intervention (formerly 
called angioplasty with stent).54
Across all models, on the other hand, HF was not statisti-
cally significant. This finding is not altogether surprising 
given the chronic nature of HF and the resources required to 
treat it. For instance, though the hospital system was designed 
under the acute model, chronic illnesses require an entirely 
Table 3. Fixed effects regression results.
Model 1: acute myocardial 
infarction
Model 2:  
pneumonia
Model 3:  
heart failure
 Coefficient SD T stat Coefficient SD T stat Coefficient SD T stat
Operating revenues/patient (H1)
 30-day readmission rate –49.63 27.45 –1.81a 30.09 27.21 1.4 –102.52 88.43 –1.16
 30-day mortality rate 790.75 483.73 1.03 –447.06 294.8 –1.52 –19.6 261.58 –0.07
 2013 528.69 485.52 1.09 269.68 468.42 0.58 95.43 488.49 0.2
 2014 1848.98 1359.84 1.36 1369.42 991.64 1.38 –120.52 796.57 –0.15
 Constant 1266.3 7738.98 0.16 17885.21 3810.89 4.69 15440.6 2877.3 5.37
 Adjusted R2 0.86 0.860 0.858  
 F statistic 2.06 28.25 3.94  
 Eta squared 0.02 0.28 0.05  
Operating expenses/patient (H2)
 30–day readmission rate –51.02 24.12 –2.11b 13.83 23.24 0.6 –84.79 84.21 –1.01
 30-day mortality rate 516.82 442.51 1.17 –353.14 287.4 –1.23 –121.43 199.76 –0.61
 2013 178.21 468.36 0.38 –0.269 423.83 0 –104.45 470.24 –0.22
 2014 1500.83 1300.12 1.15 1031.36 932.86 1.11 21.45 716.04 0.03
 Constant 5330.8 7051.4 0.76 16817.81 3619.74 4.65 15952.04  
 Adjusted R2 0.86 0.93 0.86  
 F statistic 6.36 9.54 8.70  
 Eta squared 0.08 0.11 0.10  
Operating margin (H3)
 30-day Readmission rate 0.011 0.091 0.12 0.089 0.052 1.72a –0.082 0.150 –0.54
 30-day Mortality rate 1.487 0.923 1.61 –0.942 0.810 –1.16 0.507 0.618 0.82
 2013 1.484 1.245 1.19 1.174 1.196 0.98 0.841 1.140 0.74
 2014 1.332 1.741 0.77 1.000 1.591 0.63 –1.031 2.839 –0.36
 Constant –21.144 15.485 –1.37 13.187 10.397 1.27 –1.628 7.735 –0.21
 Adj R2 0.587 0.574 0.534  
 F statistic 1.55 0.32 4.86  
 Eta squared 0.02 0.004 0.06  
Note. CI = confidence interval.
aIndicates significance at the 90% CI.
bIndicates significance at the 95% CI.
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different approach to care.55,56 While “the majority of chronic 
illness care is performed within the primary care setting,”55 it 
is a phenomenon that requires linkages and resources at the 
level of community, the healthcare system, and the provider 
organization. Consequently, the lack of a statistically signifi-
cant relationship across all financial measures with HF read-
missions may be due to treatment being regularly obtained in 
alternate locations like primary care facilities or other outpa-
tient clinics. Additionally, when considering a condition like 
HF, illness severity may play a significant role.56 As such, 
future studies may consider stratifying by risk as a way to 
obtain a more nuanced understanding of the impact of reduc-
ing HF readmission rates on financial performance.
In the case of PN, a higher readmission rate was associ-
ated with a higher operating margin. An explanation for this 
finding would be that, possibly hospitals discharge patients 
too soon to save on costs of service, but only to incur 
expenses from readmissions or having to pay penalties. 
Patients who come back to hospitals with readmissions may 
have a higher severity of illness as compared to when they 
presented first. For instance, a patient who acquired a Central 
Line Infection at the hospital when they were being treated 
for PN, would return with a complication, thus requiring 
more resources on the part of the hospital. Subsequently, 
hospitals incur a greater use of hospital resources. This is a 
penny-wise pound-foolish type of situation in which the pur-
suit of lower cost by hospitals may eventually lead to slight 
increase in operating margin in the short term.11 In the long 
run, as expenses keep getting higher, continued readmissions 
may result in decreased profitability. As an alternate explana-
tion, it may be such that the HRRP program with a capped 
3% penalty may not be effective if hospitals are making a 
profit with higher reimbursements despite the penalty. 
However, that is likely to happen in very few cases because 
the rates of those reimbursements would be lower while the 
severity of readmitted patients would be higher.
Findings from our study are consistent with earlier studies 
that have provided evidence of either no association or incon-
sistent association between readmission rates and profitabil-
ity.11,12 Studies have shown that hospitals may not have the 
incentive to improve quality outcomes if the added cost of 
improving quality scores is high.57 Other studies have found 
that increase in treatments through a greater number of diag-
nostic tests, treatments, and use of technology may contribute 
to increase in profits, even though it means that the care may 
not be effective.39 This could be a possible rationale behind 
those occurrences where operating revenues and margin 
increase even with higher readmissions. Quality enhancements 
need expenditure and usage of resources. In other situations, 
hospitals that do invest the time and efforts in reducing read-
mission rates also see increasing profit margins because they 
may be able to reduce wasteful expenditure on readmissions.
It is important to acknowledge the limitations of our 
study. Findings from this study may be limited in generaliz-
ability because our dataset is small and consists of hospitals 
only in the state of Washington. Even though a small dataset 
provides a snapshot of the possible relationship between 
readmission rates and profitability, a bigger dataset may 
allow us to see stronger associations. Another limitation 
includes potential endogeneity in case of AMI, in which hos-
pitals that have higher operating revenue may be able to 
invest more resources in reducing readmission rates. 
Additionally, the inpatient and outpatient revenues and 
expenses were combined in this study. Future scholars should 
consider separating the inpatient and outpatient data as an 
alternative approach to analysis. There is also a chance that 
those hospitals with higher operational efficiency are more 
likely to invest in readmission reduction programs. Future 
research should examine the role that operational efficiency 
may play in the adoption and execution of such program-
ming. Alternately, one of the strengths of this study, which 
also explains the difference in findings between our study 
and previous studies in this line of research, is the use of 
fixed effects regression as our methodology. This methods 
account for the variation in policies regarding readmission 
reduction across hospitals and time periods. While some hos-
pitals may discharge patients sooner to achieve short term 
cost savings by conserving on beneficial therapeutic ser-
vices, others may have efficient quality improvement strate-
gies to properly manage high readmissions. Future studies 
should expand on our study by using a larger dataset that 
includes data from more states and include more time peri-
ods to gain a better understanding of the association between 
readmission rates and financial performance. Additionally, 
prospective studies can demonstrate the lag effects of read-
mission rates on operating margin.
This research has implications both for administrators as 
well as policy makers. Findings from this study inform health-
care managers that policies regarding proper discharge should 
be made carefully so as to avoid unnecessary readmissions 
and wasteful expenditure. Our findings would guide managers 
in strategizing how to change health management practices to 
achieve a balance between reducing readmission rates and 
maintaining profitability. Additionally, our research assists 
policymakers in gaining a broader understanding of ways in 
which transparency in readmission rates including financial 
penalties and lower reimbursements associate with hospitals’ 
financial performance across revenues, expenses, and mar-
gins. In conclusion, hospitals need to ensure that they deliver 
high-quality performance including low readmission rates 
while being financially viable in the long term.
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